(Press-News.org)
New research from the University of Sydney’s Charles Perkins Centre has found that genes play an active role in shaping the bacteria found in our gut, questioning the idea that gut health is influenced only by diet.
The gut microbiome is increasingly seen as vital to overall health, with Australia's gut health supplement industry valued at over $400 million in 2024.
“After decades of research linking the gut microbiome to almost every chronic disease, it may seem like we’re all being held hostage by the bugs that live inside us,” said Dr Stewart Masson from the Charles Perkins Centre, first author of the new study in EMBO J.
“While gut microbes certainly influence everything from diabetes to depression, this study has revealed that our bodies aren’t just passive hosts.”
The researchers found that mice with certain genes produced natural peptides – or small proteins – called alpha-defensins, which act as gardeners of the microbiome, shaping which gut bugs thrive and weeding out undesirable bacteria. The mice with alpha-defensins had healthier microbiomes and were much less likely to develop insulin resistance, a key cause of type 2 diabetes and heart disease.
Importantly, alpha-defensin peptides are also found in people, which the researchers believe is highly relevant to human health.
Professor David James, joint Interim Academic Director of the Charles Perkins Centre, said: “Our work suggests that our DNA actively works to shape a healthy gut microbiome, and these microbial-shaping peptides could one day, if harnessed, become a new weapon against obesity and diabetes.”
INSULIN RESISTANCE, CHRONIC DISEASE AND DIET: GENES PLAY IMPORTANT ROLE
The researchers were originally studying genetic influences of insulin resistance in mice when they noticed that certain mice were less prone to the condition had genes that changed the production of defensin peptides in cells lining the intestine.
“Defensin peptides are present in a wide range of organisms, from plants to mice and humans, and are thought to be the earliest precursor to an immune system,” Dr Masson said. “Mice and humans seem to have evolved many defensin genes, each making a different peptide. It is thought that this diversity allows our immune system to fend off a wide range of attackers”.
The researchers found that mice whose genes made more alpha-defensins were healthier than mice who made less.
To test these findings, the researchers then synthesised the defensin peptides in the lab and fed them to mice without the genes. The experiments showed that this protected mice from the negative effects of an unhealthy diet.
“These initial findings are exciting because they show we can potentially use peptides to address chronic diseases from diabetes to obesity to depression – all of which have been linked to the health of our microbiome over decades of research,” Dr Masson said.
Critically, while certain genetic strains of mice gained benefit from the defensin peptides, others did not and were, in fact, worse off.
“This shows the importance of ‘personalised medicine’, or tailoring treatments to complement the genes of individuals rather than taking a one-size-fits-all approach to medications,” Dr Masson said. “We need to establish how different individuals and microbiomes react to the same treatments, whether they be defensin peptides or common medications already in use.”
HOW CAN BENEFICIAL BACTERIA BOOST HEALTH
Dr Masson said the team is now looking to expand on the research and explore how it applies to human health.
“We’re looking to measure these peptides in humans. In particular, measuring them in the gut and looking at the relationship with metabolic health and the microbiome.
“I'm also interested in defensins beyond diabetes. We know the microbiome is involved in many chronic diseases like cancer; I suspect defensins could play a role in this field.”
Professor James said that this illustrates the potential power of precision medicine.
“Our work clearly shows how manipulating the gut microbiome with these peptides benefits some but not others,” he said. “This highlights both the potential of precision medicine and the potential dangers of trying to alter our gut microbiome, such as with supplements or even fad diets, before we know more about how our bodies maintain healthy microbiomes unique to each of us.
“We are at the foothills of precision medicine, and the picture looks promising, but we have a long way to go.”
-ENDS-
END
Research led by Liverpool School of Tropical Medicine and the Malawi-Liverpool-Wellcome Programme shows that over half of hospital patients with breathlessness had died within a year of admission (51%), as opposed to just 26% of those without the symptom.
Most of these patients had more than one condition that cause breathlessness, including pneumonia, anaemia, heart failure and TB.
The findings demonstrate the importance of integrated, patient-centred care, researchers say, to tackle the burden of high mortality ...
Summary
Led by Assistant Professor Kou Li, a research group in Chuo University, Japan, has developed a synergetic strategy among non-destructive terahertz (THz)–infrared (IR) photo-monitoring techniques and ultrabroadband sensitive imager sheets toward demonstrating in-line realtime multi-scale quality inspections of pharmaceutical agent pills, with a recent paper publication in Light: Science & Applications.
While non-destructive in-line monitoring at manufacturing sites is essential for ...
For millennia, Indigenous people living in Alaska and Canada’s Yukon territory have relied on Chinook salmon. The large, fatty fish provide essential nutrients for Arctic living and have influenced traditions and languages across generations.
But over the past three decades, many communities have been unable to fish Chinook amid a sharp salmon population decline.
The situation could worsen as climate change warms rivers in the Arctic, stunting salmon growth, according to a study published August 6 in Scientific Reports led by the University of Colorado Boulder.
“The ...
(MEMPHIS, Tenn. – September 10, 2025) Mitochondria act as energy factories in cells and have their own, separate DNA. Mutations to mitochondrial DNA (mtDNA) have been observed in cancer, but it has been unclear how these changes might affect cancer growth. To find answers, St. Jude Children’s Research Hospital scientists combined computational tools and DNA sequencing technologies to examine these mtDNA mutations in cancer cells closely. Their new method lets scientists pinpoint when these mutations occur, how they change as cancer develops and whether they affect how cancer ...
In a new study published in Science Advances Sept. 10, a team of UC Davis researchers tracked the movement of fluorescent particles inside the cells of microscopic worms, providing unprecedented insights into cellular crowding in a multicellular animal. They found that the cytoplasm inside the worms was significantly more crowded and compartmentalized than in single-celled yeast or mammalian tissue culture cells, which are more commonly used to gauge internal cellular dynamics.
This difference highlights the importance ...
Although Latinos and Hispanics are at elevated risk for Alzheimer’s disease and account for almost half of Los Angeles County’s population, a recent UCLA Health study finds that accessible digital resources for these communities remain in short supply since the COVID-19 pandemic.
The study, published in the Journal of Medical Internet Research, found only a handful of the 15 websites from the county’s top Alzheimer’s disease organizations had features or tools to improve access for Latino and Hispanic families during and amid the aftermath of the COVID-19 pandemic.
Senior ...
IMPERIAL COLLEGE LONDON PRESS RELEASE
Peer Reviewed / Observational study / People
Under STRICT EMBARGO until:
Wednesday 10th September 2025
23:30 (UK Time) / 18:30 (US Eastern Time)
Chronic disease deaths decline globally, but progress is slowing
**Country-level data available, see notes to editors**
Mortality from chronic diseases fell in 80% of countries in the decade leading up to the COVID-19 pandemic (2010-2019)
Progress has slowed, with 60% of countries performing worse than in the preceding decade
Among high-income ...
Death rates from chronic diseases have fallen in four out of five countries around the world in the last decade - but progress has slowed, suggests an analysis led by researchers at Imperial College London and published in The Lancet.
In recent decades there have been many global and national political pledges and plans to improve prevention and treatment of chronic diseases (also called non-communicable diseases - NCDs), such as cancer, cardiovascular disease, diabetes, kidney disease, liver disease, neurological conditions and others. This includes the UN Sustainable Development Goal of reducing premature mortality from NCDs by one-third by 2030.
This study is believed to be the first ...
A meta-analysis of 17 trials including over 9,000 toddlers found no evidence that parent-focused early childhood obesity prevention programs have an impact on young children's BMI.
Authors say their findings underscore the need to re-think current behavioural approaches to prevent obesity in early childhood and stress the need for broader, coordinated and resourced public health action.
Existing approaches to parent-focused behavioural programs delivered up to 12 months of age which aim to combat childhood obesity are ...
UCL Press Release
Under embargo until Thursday 11 September 2025, 00:01 UK time
Peer reviewed, qualitative study
Study sheds light on hurdles faced in transforming NHS healthcare with AI
Implementing artificial intelligence (AI) into NHS hospitals is far harder than initially anticipated, with complications around governance, contracts, data collection, harmonisation with old IT systems, finding the right AI tools and staff training, finds a major new UK study led by UCL researchers.
Authors of the study, published in The Lancet eClinicalMedicine, say ...
